Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Profit After Tax: 2009-2024

Historic Profit After Tax for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$6.5 million.

  • Cumberland Pharmaceuticals' Profit After Tax fell 26.23% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.38%. This contributed to the annual value of -$6.5 million for FY2024, which is 2.35% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Profit After Tax stood at -$6.5 million for FY2024, which was down 2.35% from -$6.3 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Profit After Tax ranged from a high of -$5.6 million in FY2021 and a low of -$6.6 million during FY2020.
  • Moreover, its 3-year median value for Profit After Tax was -$6.3 million (2023), whereas its average is -$6.2 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first grew by 28.07% in 2020, then declined by 12.05% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Profit After Tax (Yearly) stood at -$6.6 million in 2020, then climbed by 15.53% to -$5.6 million in 2021, then declined by 0.95% to -$5.7 million in 2022, then declined by 12.05% to -$6.3 million in 2023, then declined by 2.35% to -$6.5 million in 2024.